CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-18 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $17.17 | $43K | 48,556 |
| 2020-05-18 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 22,488 | ||
| 2020-04-20 | Anicetti Vincent R Chief Operating Officer | Sale | −5,150 | $17.00 | $88K | 47,846 |
| 2020-04-17 | Anicetti Vincent R Chief Operating Officer | Option exercise | +5,000 | $2.50 | $13K | 57,996 |
| 2020-04-17 | Anicetti Vincent R Chief Operating Officer | Sale | −5,000 | $15.57 | $78K | 52,996 |
| 2020-04-17 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 24,988 | ||
| 2020-03-03 | Wahlstrom Mats Director | Sale | −113,844 | $20.09 | $2.3M | 204,222 |
| 2020-03-03 | Wahlstrom Mats Director | Sale | −4,222 | $20.89 | $88K | 200,000 |
| 2020-02-19 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +3,159 | $10.05 | $32K | 50,000 |
| 2020-02-19 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,159 | $22.33 | $71K | 46,841 |
| 2020-02-19 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,159 | 101,569 | ||
| 2020-02-18 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 60,496 |
| 2020-02-18 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $21.64 | $54K | 57,996 |
| 2020-02-18 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $12.70 | $32K | 60,496 |
| 2020-02-18 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $21.64 | $54K | 57,996 |
| 2020-02-18 | Anicetti Vincent R Chief Operating Officer | Sale | −5,000 | $21.64 | $108K | 52,996 |
| 2020-02-18 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 29,988 | ||
| 2020-02-18 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 45,000 | ||
| 2020-01-17 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 65,496 |
| 2020-01-17 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $19.57 | $49K | 62,996 |
Page 16 of 39 · 768 trades